CA
CME icon

Cullinan Associates’s CME Group CME Stock Holding History

Cullinan Associates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.06M Sell
30,687
-8,066
-21% -$2.4M 0.73% 36
2025
Q4 		$10.6M Buy
38,753
+3,303
+9% +$898K 0.72% 35
2025
Q3 		$9.58M Buy
35,450
+16,050
+83% +$4.37M 0.62% 41
2025
Q2 		$5.35M Buy
19,400
+446
+2% +$121K 0.35% 59
2025
Q1 		$5.03M Buy
18,954
+1,307
+7% +$322K 0.36% 60
2024
Q4 		$4.1M Buy
17,647
+15,177
+614% +$3.49M 0.26% 75
2024
Q3 		$561K Sell
2,470
-1,360
-36% -$281K 0.03% 172
2024
Q2 		$753K Hold
3,830
– – 0.04% 162
2024
Q1 		$825K Sell
3,830
-10
-0.3% -$2.1K 0.05% 165
2023
Q4 		$809K Sell
3,840
-400
-9% -$85.3K 0.05% 158
2023
Q3 		$849K Sell
4,240
-1,200
-22% -$239K 0.05% 150
2023
Q2 		$1.01M Sell
5,440
-100
-2% -$18.5K 0.06% 157
2023
Q1 		$1.06M Sell
5,540
-85
-2% -$15.4K 0.06% 154
2022
Q4 		$946K Sell
5,625
-550
-9% -$95.6K 0.05% 166
2022
Q3 		$1.09M Sell
6,175
-65
-1% -$12.8K 0.07% 139
2022
Q2 		$1.28M Buy
6,240
+125
+2% +$26.5K 0.08% 131
2022
Q1 		$1.46M Sell
6,115
-2,880
-32% -$676K 0.08% 130
2021
Q4 		$2.06M Buy
8,995
+360
+4% +$79.2K 0.1% 122
2021
Q3 		$1.67M Buy
8,635
+300
+4% +$60.8K 0.09% 124
2021
Q2 		$1.77M Sell
8,335
-37,400
-82% -$7.9M 0.1% 121
2021
Q1 		$9.34M Buy
45,735
+208
+0.5% +$41K 0.54% 56
2020
Q4 		$8.29M Buy
45,527
+6,570
+17% +$1.12M 0.5% 55
2020
Q3 		$6.52M Sell
38,957
-1,900
-5% -$320K 0.42% 64
2020
Q2 		$6.64M Buy
40,857
+40
+0.1% +$7.17K 0.47% 56
2020
Q1 		$7.06M Hold
40,817
– – 0.58% 46
2019
Q4 		$8.19M Buy
40,817
+465
+1% +$95.4K 0.55% 47
2019
Q3 		$8.53M Sell
40,352
-11,143
-22% -$2.33M 0.61% 48
2019
Q2 		$10M Sell
51,495
-1,110
-2% -$205K 0.73% 35
2019
Q1 		$8.66M Buy
52,605
+7,220
+16% +$1.28M 0.65% 42
2018
Q4 		$8.54M Sell
45,385
-35
-0.1% -$6.46K 0.71% 32
2018
Q3 		$7.73M Buy
45,420
+3,610
+9% +$608K 0.56% 50
2018
Q2 		$6.85M Buy
41,810
+2,810
+7% +$459K 0.52% 51
2018
Q1 		$6.31M Sell
39,000
-290
-0.7% -$46.2K 0.48% 53
2017
Q4 		$5.74M Sell
39,290
-12,340
-24% -$1.76M 0.42% 66
2017
Q3 		$7M Buy
51,630
+50
+0.1% +$6.32K 0.54% 52
2017
Q2 		$6.46M Sell
51,580
-4,295
-8% -$514K 0.5% 53
2017
Q1 		$6.64M Sell
55,875
-197
-0.4% -$23.7K 0.54% 52
2016
Q4 		$6.47M Sell
56,072
-2,583
-4% -$287K 0.55% 54
2016
Q3 		$6.13M Buy
58,655
+3,705
+7% +$387K 0.52% 49
2016
Q2 		$5.35M Buy
54,950
+150
+0.3% +$14.2K 0.44% 60
2016
Q1 		$5.26M Sell
54,800
-170
-0.3% -$15.5K 0.45% 60
2015
Q4 		$4.98M Buy
54,970
+22,970
+72% +$2.16M 0.43% 59
2015
Q3 		$2.97M Sell
32,000
-100
-0.3% -$9.51K 0.27% 85
2015
Q2 		$2.99M Sell
32,100
-75
-0.2% -$7K 0.25% 89
2015
Q1 		$3.05M Buy
+32,175
New +$2.98M 0.24% 89

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cullinan Associates's CME Position: Q1 2026 in Review

Cullinan Associates reduced its CME Group (CME) stake by 21% in Q1 2026, selling an estimated $2.4M and leaving 30,687 shares worth $9.06M. The position accounts for 0.73% of the portfolio, ranked #36.

Cullinan Associates first reported a position in CME in Q1 2015 and has held it in 45 quarters since. The position peaked at $10.6M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Cullinan Associates held 30,687 shares of CME Group worth $9.06M as of Q1 2026.
  • Cullinan Associates sold 8,066 CME Group shares in Q1 2026, an estimated $2.4M.
  • CME Group made up 0.73% of Cullinan Associates's portfolio in Q1 2026, its #36 holding.
  • Cullinan Associates first reported a position in CME Group in Q1 2015 and has held it in 45 quarters since.
  • Cullinan Associates's CME Group position peaked at $10.6M in Q4 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.